Aratana Therapeutics is a wholly owned subsidiary of
@Elanco.
@Elanco.
Location: United States, Kansas, Leawood
Employees: 51-200
Total raised: $40M
Founded date: 2010
Investors 2
| Date | Name | Website |
| - | Cultivian ... | cultivians... |
| - | KU Leuven ... | lrd.kuleuv... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 13.12.2015 | - | $40M | - |
Mentions in press and media 6
| Date | Title | Description |
| 29.04.2019 | Term Sheet — Monday, April 29 | GROWTH AT ALL COSTS Good morning, Term Sheet readers — I’m back! Paid Content How can you protect what you can't see? From ExtraHop I read a Wall Street Journal column titled, “Why Investors Don’t Care That Snap and Lyft Are Hemorrhaging Mo... |
| 09.11.2017 | 10 Fastest Growing Tech Companies in the US | Every entrepreneur knows that if you're not growing, you're dying. It's not enough for companies to remain stagnant in the business world, as new and innovative ideas are popping up every day ready to dethrone even the most solidified of un... |
| 13.12.2015 | Aratana Therapeutics Receives $40M Credit Facility | Aratana Therapeutics (NASDAQ: PETX), a Kansas City, Kansas-based pet therapeutics company, received a $40m credit facility. Backers included Square 1 Bank, a division of Pacific Western Bank, and Oxford Finance LLC. The financing refinanced... |
| 30.10.2013 | Which venture capital firm’s healthcare investment picks secured the most IPOs? | I won’t get into Aratana Therapeutics (Nasdaq: PETX) because the biopharmaceutical company develops treatments for animals. Acceleron Pharma: (Nasdaq: XLRN) raised $96.7 million after it priced at the high end of its share price range. The ... |
| - | Which venture capital firm’s healthcare investment picks secured the most IPOs? | Biotechnology and healthcare companies have been going public at a good clip this year, at a rate that overshadows the past few years. But initial public offerings are not what they used to be. Although they used to mark an exit for a compa... |
| - | Aratana Therapeutics acquires Okapi Sciences NV | Aratana Therapeutics, Inc. (Nasdaq: PETX), a biopharmaceutical company focused on the licensing, development and commercialization of innovative medications for pets, today announced, that it has acquired Okapi Sciences NV, a Belgium-based ... |